Sigilon Therapeutics, Inc.
SGTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$43,561 | -$77,311 | -$54,608 | -$43,925 |
| Dep. & Amort. | $1,264 | $1,118 | $854 | $675 |
| Deferred Tax | $0 | $3 | -$854 | $207 |
| Stock-Based Comp. | $5,901 | $6,149 | $3,127 | $2,073 |
| Change in WC | -$19,267 | -$13,420 | -$2,547 | -$10,890 |
| Other Non-Cash | $4,189 | $5,056 | -$7,620 | $1,786 |
| Operating Cash Flow | -$51,474 | -$78,405 | -$61,648 | -$50,074 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$537 | -$1,834 | -$972 | -$1,209 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$42,524 | -$16,226 | $0 | $0 |
| Inv. Sales/Matur. | $30,750 | $0 | $0 | $0 |
| Other Inv. Act. | $230 | $0 | $0 | $0 |
| Investing Cash Flow | -$12,081 | -$18,060 | -$972 | -$1,209 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $61 | -$622 | $132,527 | $0 |
| Stock Repurch. | $0 | -$622 | $51,723 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,606 | $1,554 | $189,397 | $63,242 |
| Financing Cash Flow | -$1,606 | $1,554 | $189,397 | $63,242 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$65,161 | -$94,911 | $126,777 | $11,959 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $108,511 | $203,422 | $76,645 | $64,686 |
| End Cash | $43,350 | $108,511 | $203,422 | $76,645 |
| Free Cash Flow | -$52,011 | -$80,239 | -$62,620 | -$51,283 |